What is a iv fluids project report?
An IV fluids project report is a detailed project report (DPR) for a sterile plant that makes intravenous solutions such as normal saline, dextrose and Ringer lactate in plastic bottles. It covers the blow-fill-seal process, water for injection system, machinery, raw materials, licensing, project cost, means of finance, five-year projections, DSCR and break-even.
Entrepreneurs and existing pharma companies use a project report on IV fluids to plan the plant and apply for a term loan; banks use it to judge whether the unit can repay.
Also known as: IV fluid manufacturing project report, DPR for IV fluid plant, BFS IV fluids project report, intravenous fluids business plan, LVP project report.
What a bank checks in an IV fluids project report
Credit officers test an IV fluid plan against a few numbers that show whether the unit can sell at tender prices and still repay. These are the values in our sample report and why each one matters.
Salt, dextrose, plastic granules and closures cost about a third of sales. A plan that shows much less is often pricing all output at private-hospital rates.
The LDPE or PP bottle costs more than the solution inside it. Banks ask how the plan copes with a rise in polymer prices.
Lenders compare it with recent state tender rates and with the NPPA ceiling price, which caps what the patient pays, not what the plant earns.
Tender payments are slow. In Year 1 of the sample, receivables of ₹267.19 lakh are the largest current asset, so they set the cash credit limit.
Values are the assumptions in our illustrative sample. Your report uses figures for your capacity, buyers and state.
IV fluids manufacturing plant cost in India
Cost depends on how many bottles a day the BFS line makes, whether the machine is Indian or imported, and the size of the clean rooms. The middle tier is the unit in our sample report; the other two are indicative ranges.
Compact unit
₹5–8 crore
About 15,000–25,000 bottles per day, one Indian BFS machine
- Machinery and WFI system₹2–3.5 crore
- Land, building and clean rooms₹1.5–3 crore
- Working capital margin₹50–90 lakh
MSME term loan, often with CGTMSE cover
Mid-size plant
₹963 lakh
43,000 bottles per day, 1,29,00,000 bottles per year
- Plant and machinery₹425.40 lakh
- Building and civil works₹233.08 lakh
- Working capital margin₹92.38 lakh
Term loan ₹722 lakh (75%), promoter ₹241 lakh
Large plant
₹20–40 crore
About 80,000–1,50,000 bottles per day, two or more lines
- Machinery, often imported₹10–22 crore
- Land, building and clean rooms₹6–12 crore
- Working capital margin₹2–4 crore
Term loan with a larger promoter share
Compact and large ranges are indicative and include land. Imported BFS machines cost well above Indian ones, so get quotations early.
IV fluids plant economics in our sample report
The sample models 43,000 bottles per day over 300 working days, starting at 60% of capacity and reaching 80% in Year 5. Bottles are priced at ₹21 each ex-factory, and a team of 75 people runs the plant.
| Land and site development | 76.53 |
|---|---|
| Building and civil works | 233.08 |
| Plant and machinery | 425.40 |
| Other fixed assets | 81.04 |
| Contingencies | 32.92 |
| Preliminary and pre-operative | 21.22 |
| Working capital margin | 92.38 |
| Total | 962.57 |
| Promoter's contribution (25%) | 240.64 |
|---|---|
| Term loan from bank (75%) | 721.93 |
| Cash credit limit (separate) | 277.16 |
| Total project cost | 962.57 |
Term loan at 10.5% with a 6-month moratorium and 54 monthly instalments; the lowest yearly DSCR is 2.06. All figures are illustrative.
IV fluids manufacturing process with BFS technology
Most new Indian units use blow-fill-seal (BFS), which the trade also calls form-fill-seal (FFS). The bottle is made, filled and closed inside one machine, so no open container is handled by people.
- Water for injection
Raw water is softened and passed through reverse osmosis, then distilled in a multi-column still into water for injection (WFI), which is stored hot and kept circulating.
- Solution preparation
IP-grade sodium chloride or dextrose is weighed and dissolved in WFI in stainless steel tanks, and each batch is checked for strength and pH.
- Filtration
The solution passes through membrane filters to remove particles before it reaches the filling machine.
- Blow, fill and seal
The machine melts LDPE or PP granules into a tube, blows it into a bottle, fills the measured volume and seals the top under filtered air.
- Terminal sterilisation
Sealed bottles go through a steam steriliser on a cycle validated for the bottle material, since LDPE softens at lower temperatures than PP.
- Leak test and inspection
Bottles are pressure-tested for leaks and checked against a light for visible particles or floating matter.
- Testing and release
Samples go through sterility and bacterial endotoxin tests, and the batch stays in quarantine until the results clear it for dispatch.
Raw materials for IV fluids
A 500 ml bottle of normal saline holds just 4.5 grams of salt, so the bottle and closure cost more than the drug. Plants buy pharma-grade granules on contract and, in the sample, hold 45 days of raw material stock.
| Raw material | Share of cost | Year 3 (₹ lakh) |
|---|---|---|
| Dextrose and sodium chloride IP | 30% | 197.58 |
| LDPE or PP granules for bottles | 45% | 296.37 |
| Water for injection consumables | 10% | 65.86 |
| Caps and rubber stoppers | 15% | 98.79 |
| Total | 100% | 658.60 |
Machinery for an IV fluids plant
More than half the machinery budget goes on the systems around the filling machine: water, clean air, sterilisation and testing.
| Machine | What it does | Sample cost (₹ lakh) |
|---|---|---|
| Form fill seal machine | Blows, fills and seals bottles in one cycle (BFS) | 191.43 |
| Water for injection plant | Pre-treatment, RO, WFI storage and hot loop | 63.81 |
| Multi column distillation unit | Distils purified water into WFI | 34.03 |
| Steam steriliser | Terminal sterilisation of filled bottles | 51.05 |
| Clean room HVAC | Filtered air and pressure zones for filling | 51.05 |
| Quality control lab | Sterility, endotoxin, particle and assay tests | 34.03 |
| Total plant and machinery | 425.40 | |
The form fill seal machine is the largest single item, at 45% of machinery cost in the sample. Get current quotations before you finalise.
Who buys IV fluids in India?
IV fluids are used in almost every hospital admission, from surgery and dialysis to dehydration and dengue care. Demand rises in the monsoon months, when fever and diarrhoea cases fill wards, so plants build stock ahead of the season.
- State medical services corporations buying through tenders
- Private and corporate hospitals
- Nursing homes and clinics
- Pharmaceutical distributors and stockists
- Dialysis and day-care centres
- Export buyers, mostly for WHO-GMP certified plants
Where a new unit wins: a bottle of fluid is heavy and cheap, so freight eats margin over long distances. A plant close to its tender zone and distributors can compete with larger makers shipping from far away.
Licences and approvals for IV fluid manufacturing
IV fluids are large volume parenterals, meaning sterile solutions of 100 ml or more, so the licence needs central as well as state approval.
| Drug manufacturing licence | Licence in Form 28D for large volume parenterals. The State Licensing Authority and the CDSCO zonal office inspect jointly, and the Central Licence Approving Authority must approve the licence before it is issued. |
|---|---|
| Good manufacturing practice | Revised Schedule M under the Drugs Rules, 1945, notified on 28 December 2023 (G.S.R. 922(E)). Design the clean rooms, HVAC and water system to it from the start. |
| Products at first grant | A new grant covers only established pharmacopoeial products, and stability studies must start right after the first batches are made. |
| Price control | Common IV fluids such as glucose injection are priced under the Drugs (Prices Control) Order, 2013, with an NPPA ceiling price for each pack. |
| GST | Drugs and medicines attract 5% GST from 22 September 2025, except those at nil rate. Confirm the HSN code for each product with your CA. |
| Pollution consent | Consent to establish and to operate from the State Pollution Control Board; the board sets the category for your plant. |
| Business registration | Udyam (MSME) and GST registration, plus a factory licence and fire NOC under state rules. |
Mistakes that weaken an IV fluids project report
- Applying for the licence before the plant is ready
CDSCO advises applying only when the premises are mostly complete. An inspection of an unfinished plant is not final, and reinspection delays push first sales past the loan moratorium.
- Leaving validation out of time and cost
HVAC validation and calibration of critical equipment are part of the licence file. Reports that skip them under-state pre-operative cost and start-up time.
- Pricing all output at private rates
Model the tender share at tender rates, and check each pack against its NPPA ceiling price, or revenue and DSCR come out too high.
- Too little working capital for tender credit
With 60 days of buyer credit and stock held until tests clear, the sample needs ₹369.54 lakh of working capital in Year 1.
- Counting products the licence does not yet cover
Only established pharmacopoeial products are allowed at first grant. Keep other infusions out of Year 1 sales until the licence is endorsed for them.
How NPCS helps you set up an IV fluids plant
- BFS line sizingChoose bottle sizes, product mix and machine output to suit your tender zone and budget.
- Clean room and utility layoutPlant layout, HVAC zones, WFI capacity and steam load planned to revised Schedule M.
- Bank-ready project reportProjections, DSCR and working capital with tender credit, in the format your lender wants.
- Licence file supportThe approvals list and documents for a large volume parenteral licence in your state.
NPCS's published client list shows 67 assignments in pharmaceuticals, including IV fluid projects for clients in India and abroad in 2025 and 2026.
What's inside the iv fluids sample report
- Introduction
- Uses and applications
- Market potential
- Manufacturing process
- Raw materials
- Plant and machinery
- Land, building and utilities
- Manpower
- Licences and approvals
- Project cost and means of finance
- Working capital
- Projected profitability
- Cash flow statement
- Projected balance sheet
- Depreciation
- Term loan repayment
- Debt service coverage
- Break-even analysis
- Financial ratios
- Key assumptions
- Conclusion
- Monthly loan repayment schedule
18 pages, five-year projections, illustrative figures.
Open sample reportFree sample or a report for your project?
| What you get | Free sample | NPCS report for your project |
|---|---|---|
| Capacity and location | Typical unit | Your capacity, site and state |
| Figures | Illustrative | Built on current prices and quotations |
| Machinery suppliers and quotations | No | Yes |
| Market survey for your region | No | Yes |
| Bank or scheme format (PMEGP, term loan) | No | Yes |
| Use for a loan application | No | Yes |
What clients say about NPCS
4.7
264 Google reviews, as of 20 Oct 2026
Clients most often mention
- feasibility reports 18
- project report 16
- helpful for startups 15
- detailed reports 8
-
Excellent experience with Niir Project Consultancy Services. Their Techno-Economic Feasibility Reports are incredibly detailed and backed by solid market data.
Piyush Singh, Google review, 2026
-
Niir Project Consultancy Services offers excellent guidance for business setup. Their market survey and feasibility reports saved us a lot of time and helped us make informed decisions. Highly recommended
Saroj Yadav, Google review, 2026 View on Google
-
In an era of information overload, NIIR stands out for its precision. Their technical consultancy and market feasibility studies are world-class.
Shrishti Gautam, Google review, 2026
-
NIIR Project Consultancy Services provides useful books and reports for students, entrepreneurs, and small businesses. Their content is easy to understand and focuses on practical ideas for starting and managing industries. Overall, NIIR is helpful for learning about business and project planning.
Raj Yadav, Google review, 2026
IV Fluids project report: frequently asked questions
How much does it cost to set up an IV fluids manufacturing plant in India?
A compact BFS unit making 15,000–25,000 bottles a day needs roughly ₹5–8 crore, and a large plant with two or more lines ₹20–40 crore, including land and working capital margin. Our sample report models a 43,000 bottles per day unit at ₹963 lakh. These are indicative figures; your own report works out the cost for your capacity, machine make and state.
What is the difference between BFS and FFS for IV fluids?
In the Indian trade both names usually mean the same thing: a machine that forms a plastic bottle from granules, fills it and seals it in one closed cycle. Strictly, form-fill-seal can also mean bags made from plastic film. Because no person handles an open container, BFS lowers contamination risk, which matters under Schedule M clean room rules.
Which licence is needed to manufacture IV fluids in India?
You need a drug manufacturing licence for large volume parenterals in Form 28D. The state drugs controller and the CDSCO zonal office inspect the plant together, and the Central Licence Approving Authority at CDSCO must approve the licence. The plant must meet revised Schedule M, and you also need Udyam, GST, pollution consent and a factory licence.
Is IV fluid manufacturing profitable?
In our illustrative sample, a 43,000 bottles per day unit earns a 33% return on investment in Year 3, breaks even at 36% of capacity and pays back in about 2.7 years. Real profit depends on your share of tender sales, polymer prices, batch rejections and how quickly government buyers pay.
Which loans or subsidies can an IV fluids unit get?
Most new plants take an MSME term loan, with a cash credit limit for working capital. Since 1 April 2025, CGTMSE can guarantee credit of up to ₹10 crore for eligible micro and small enterprises. Existing pharma units upgrading to revised Schedule M can claim up to ₹1 crore under the Department of Pharmaceuticals' RPTUAS. Confirm current terms with your bank.
Which IV fluids can a new plant make?
A new licence covers established pharmacopoeial products, so most plants start with sodium chloride 0.9%, dextrose 5% and 10%, dextrose with sodium chloride and Ringer lactate, in 100 ml to 1000 ml bottles. Other infusions, such as metronidazole or mannitol, can be added once the licence is endorsed for them.
Is the sample report free and can I use it for a loan?
Yes, the IV fluids project report PDF on this page is free to view and download. It is an illustrative report that shows the format and depth of an NPCS IV fluids project report; its figures are representative and not from a real project, so do not submit it to a bank. For a loan, NPCS prepares a report for your own capacity, location and lender.
Sources and references
- Guidance to applicants for grant of licence to manufacture LVPsCentral Drugs Standard Control Organisation (CDSCO), checked Oct 2026
- Guidelines on I.V. fluids storage, distribution and administration (LVP/D/001)Central Drugs Standard Control Organisation (CDSCO), checked Oct 2026
- Lok Sabha unstarred question 864: revised Schedule M (G.S.R. 922(E), 28.12.2023)Ministry of Health and Family Welfare, Lok Sabha, checked Oct 2026
- Scheme for Strengthening of Pharmaceutical Industry: revised guidelines (RPTUAS)Department of Pharmaceuticals, checked Oct 2026
- Corrigendum to RPTUAS guidelines, 21 March 2026Department of Pharmaceuticals, checked Oct 2026
- Review order on ceiling price of Glucose 10% injection under DPCO 2013Department of Pharmaceuticals, checked Oct 2026
- FAQs on GST rate changes, September 2025GST Council, checked Oct 2026
- Credit Guarantee Scheme for Micro and Small EnterprisesOffice of the Development Commissioner (MSME), checked Oct 2026
The NPCS project team, led by Ajay Kumar Gupta
This page and its sample report are prepared and reviewed by the NPCS project team, which has written techno-economic feasibility studies and detailed project reports since 1994.
Ajay Kumar Gupta founded Niir Project Consultancy Services (NPCS) and leads the organisation. With 40 years of experience in MSME project consulting, he has built the team that has delivered more than 28,000 project reports for clients worldwide, helping entrepreneurs plan and finance profitable manufacturing businesses.
- Published
- Last updated
- Next review
- Oct 2027
- Reviewed by
- NPCS project team
This page is reviewed every 12 months, or sooner when scheme limits, GST rates, BIS rules or pollution categories change. The sample report is illustrative: its figures are generated from industry-typical ratios for a unit of this size, checked so every statement balances, and are not taken from any client project.